The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
Abstract
Alzheimer disease (AD) is a neurodegenerative disorder and the most common form of dementia. Histopathologically is characterized by the presence extracellular neuritic plaques and with a large number of neurons lost. In this paper, we design a new nanomaterial, graphene quantum dots (GQDs) conjugated neuroprotective peptide glycine-proline-glutamate (GQDG) and administer it to APP/PS1 transgenic mice. The in vitro assays including ThT and CD proved that GQDs and GQDG could inhibit the aggregation of Aβ1-42 fibrils. Morris water maze was performed to exanimate learning and memory capacity of APP/PS1 transgenic mice. The surface area of Aβ plaque deposits reduced in the GQDG group compared to the Tg Ctrl groups. Furthermore, newly generated neuronal precursor cell and neuron were test by immunohistochemical. Besides, neurons were impregnated by DiI using gene gun to show dendritic spine. Results indicated enhancement of learning and memory capacity and increased amounts of dendritic spine were observed. Inflammation factors and amyloid-β (Aβ) were tested with suspension array and ELISA, respectively. Several pro-inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-33, IL-17α, MIP-1β and TNF-α) had decreased in GQDG group compared with Control group. Reversely, anti-inflammatory cytokines (IL-4, IL-10) had increased in GQDG group compared with Control group. Thus, we demonstrate that the GQDG is a promising drug in treatment of neurodegenerative diseases such as AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Xiao et al. (2016) used graphene quantum dots (GQDs) coated with glycine-proline-glutamate in APP/PS1 transgenic mice. The aggregation of amyloid plaque along with the levels of pro-inflammatory cytokines was reduced whereas the levels of anti-inflammatory cytokines increased, thus demonstrating strong potential as a therapy in AD [112].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [112]
Citations
Cites
Preparation of Graphitic Oxide
Hummers, W. S., & Offeman, R. E. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01539a017 · Cited by 30,194
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Graphene and Graphene Oxide: Synthesis, Properties, and Applications
Zhu, Y., Murali, S., Cai, W., Li, X., Suk, J. W., Potts, J. R., & Ruoff, R. S. (2010) · Advanced Materials · doi:10.1002/adma.201001068 · Cited by 10,653
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Nano-graphene oxide for cellular imaging and drug delivery
Sun, X., Liu, Z., Welsher, K., Robinson, J. T., Goodwin, A. P., Zaric, S., & Dai, H. (2008) · Nano Research · doi:10.1007/s12274-008-8021-8 · Cited by 3,318
LeVine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,284
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 2×
“[4] Karran E, Mercken M, De Strooper B.”
BackgroundAmyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Strongly green-photoluminescent graphene quantum dots for bioimaging applications
Zhu, S., Zhang, J., Qiao, C., Tang, S., Li, Y., Yuan, W., Li, B., Tian, L., Liu, F., Hu, R., et al. (2011) · Chemical Communications · doi:10.1039/c1cc11122a · Cited by 1,601
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–169 of 169
Wang, S., Wang, S., Wang, Z., Dong, J., Zhang, M., Wang, Y., Wang, J., Jia, B., Luo, Y. M., & Yin, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14716 · Cited by 12
Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
Li, T., Hou, X., Yu, Q., Duan, X., Yan, P., Zhu, H., Xie, Z., & Zhang, H. (2021) · Nano Research · doi:10.1007/s12274-021-3865-2 · Cited by 12
Discovery of Novel Drug Candidates for Alzheimer’s Disease by Molecular Network Modeling
Zhou, J., Li, Q., Wu, W., Zhang, X., Zuo, Z., Lu, Y., Zhao, H., & Wang, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.850217 · Cited by 12
Graphene Quantum Dots Inhibit Lipid Peroxidation in Biological Membranes
Kim, J.-H., Johnson, D. H., Bharucha, T. S., Yoo, J. M., & Zeno, W. F. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00688 · Cited by 11
Hou, T., Yang, Q., Ding, M., Wang, X., Mei, K., Guan, P., Wang, C., & Hu, X. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114182 · Cited by 12
Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements
Nayak, U. Y., Halagali, P., Panchal, K. N., Tippavajhala, V. K., Mudgal, J., Radhakrishnan, R. A., & Manikkath, J. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128328722240828184410 · Cited by 11
Biomaterials in Alzheimer's Disease: An Anti‐Neuroinflammatory Perspective
Huang, N., Huang, W., Wang, M., Shi, J., Luo, Y., & Huang, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500498 · Cited by 13
Rastogi, V., Jain, A., Kumar, P., Yadav, P., Porwal, M., Chaturvedi, S., Chandra, P., & Verma, A. K. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2238250 · Cited by 10
Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics
Suh, M., & Lee, D. S. (2018) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-018-0550-9 · Cited by 8
Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 9
Quantum dots in neurotheranostics for the treatment of Alzheimer’s disease
Sharma, T., Bashir, B., Sharma, P., andotra, N., Singh, S. K., Singh, T. G., & Vishwas, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102876 · Cited by 9
Das, A., Jana, G., Sing, S., & Basu, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131703 · Cited by 8
Multifunctional graphene oxide for bioimaging: emphasis on biological research
Hwang, D. W., Hong, B. H., & Lee, D. S. (2017) · European Journal of Nanomedicine · doi:10.1515/ejnm-2016-0036 · Cited by 8
Inhibition of lysozyme fibrillation by functional groups in graphene oxide quantum dots
Yang, Y., Xie, Y., Wang, Q., & Wu, X. (2022) · Chemical Physics Letters · doi:10.1016/j.cplett.2022.139749 · Cited by 8
Nallamuthu, I., Fathima, S. J., & Khanum, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00012-2 · Cited by 8
Cui, L., Zhang, Q., Zhang, Y., Li, T., Li, M., Yuan, J., Wu, Z., Zhang, Y., Kong, H., Qu, H., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1222415 · Cited by 7
Quantum dot-based nanodiagnostics for neurodegenerative disorders advances and future perspectives
Pınar, Z. N., Özkan, M., & Ihlamur, M. (2025) · Next research. · doi:10.1016/j.nexres.2025.101024 · Cited by 8
From Synthesis to Application: The Transformative Role of Graphene-Based Quantum Dots in Biomedicine
Huang, M., Dissanayaka, W. L., & Yiu, C. K. Y. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01791 · Cited by 7
Tosto, R., Zimbone, S., Sabatino, G., Natale, G. D., Giuffrida, M. L., Tomasello, M. F., Lanzanò, L. L., Campagna, T., Covaceuszach, S., Vecchio, G., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400431 · Cited by 7
Advances in Deep Brain Imaging with Quantum Dots: Structural, Functional, and Disease-Specific Roles
Connor, T., Weerasinghe, H., Lathia, J. D., Burda, C., & Yıldırım, M. (2024) · Photonics · doi:10.3390/photonics12010003 · Cited by 7
Wu, T., Xue, L., Li, Y., Liu, X., & Tang, M. X. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100244 · Cited by 7
Pan, Y., Hou, G., Wang, X., Ran, X., Liu, P., & Guo, L. (2023) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2023.127522 · Cited by 6
Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine
Maisam, M., Khan, M. T., Lodhi, M. S., Mou, K., Liu, Z., & Wei, D. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810258 · Cited by 7
“The small size and large surface area of GQDG allowed it to pass through the Madin-Darby Ca-nine Kidney (MDCK) cell monolayer and selectively interact with the hydrophobic group of A β 1-42 protein, leading to increased inhibition and improved memory and learning in mice treated for AD [254].”
BackgroundSampaio‐Dias, I. E., Santejo, M., Silva-Reis, S. C., Liz, M. A., Alcoholado, C., Algarra, M., Xerardo Garcia-mera, B., & Rodríguez-Borges, J. E. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00339 · Cited by 6
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease
Yadav, A. K., & Mazahir, F. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220420133059 · Cited by 6
Patel, V., & Shah, J. (2023) · Nano Express · doi:10.1088/2632-959x/ad100d · Cited by 5
Quantum Dots in Biomedical Applications: Recent Advancements and Future Prospects
Ahmed, S. A., Nayak, A. K., Ansari, M. T., Sherikar, A. K., Siddique, M. U. M., Alkahtani, S. H., Ali, S., Tabish, M., Khatoon, S., Darraj, A. Q., et al. (2023) · Advances in material research and technology · doi:10.1007/978-3-031-28263-8_7 · Cited by 5
Sampaio‐Dias, I. E., da Silva, L. P., Silva, S. G., Garcı́a-Mera, X., & Rodríguez-Borges, J. E. (2020) · Green Chemistry · doi:10.1039/d0gc00143k · Cited by 5
Al‐Muhanna, M. K., Alghamdi, A. A., Alrfaei, B. M., Afzal, M., Al-Subaiee, R., & Haddadi, R. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2024-0128 · Cited by 5
“In contrast, the levels of anti-in fl ammatory cytokines (IL-4, IL-10) were higher in the GQDG group compared to the control group [131].”
Dai, W., Zhao, M., Chen, C., Zhou, C., Wang, P., Yang, Z., Gao, S., Lu, Y., Zhang, J., & Liu, X. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00569 · Cited by 4
Microbial sensing and antimicrobial properties of graphene quantum dots
Oves, M., Ansari, M. A., Rauf, M. A., Hemdan, B. A., & Ismail, I. M. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85721-5.00003-0 · Cited by 4
Quantum Dots: Functionalization and Theranostic Applications
Sonam, S., Patel, P. C., Pandey, D., Sharma, A., & Jain, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0538-6_10 · Cited by 5
Recent Advances of Carbon dots for Treatment of Alzheimer’s and Parkinson’s Diseases
Vedhanayagam, M. (2023) · International Journal of Advanced Nano Computing and Analytics · doi:10.61797/ijanca.v2i1.240 · Cited by 4
Manna, S., Banerjee, S., De, A., Banerjee, S., Das, S., Rakshit, P., K, A. K. S., Sen, K. K., & De, S. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385314533240824090949 · Cited by 4
Gyasi, P. A., Amu‐Darko, J. N. O., Sun, B., Issaka, E., Ntim, S. Y., Enyan, M., & Hussain, S. (2025) · Nano Select · doi:10.1002/nano.70024 · Cited by 4
“In a mouse model of AD, Xiao et al. investigated the neuroprotective potential of graphene quantum dots (GQDs) coupled with the neuroprotective peptide glycine-proline-glutamate (GPE), also known as GQDG [168].”
Evolution of Detecting Early Onset of Alzheimer’s Disease: From Neuroimaging to Optical Immunoassays
Hsiao, W. W., Angela, S., Le, T., Ku, C., Hu, P., & Chiang, W. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221202 · Cited by 4
Nanobiomaterials for neural regenerative medicine
Budama‐Kilinc, Y., Özdemir, B., Zorlu, T., Gök, B., & Egil, A. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820223-4.00002-4 · Cited by 4
Zhu, R., Kim, G., Rajewski, B. H., Angera, I. J., Valle, J. R. D., & Wang, Y. (2025) · Advanced NanoBiomed Research · doi:10.1002/anbr.202500065 · Cited by 3
Chen, J., Guo, N., Ruan, Y., Mai, Y., Liao, W., & Feng, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1105095 · Cited by 3
“Both microglia (Xiao et al., 2016) and astrocytes (Velázquez-Moctezuma et al.”
BackgroundSelf-citationRETRACTED: Development of carbon dots to manage Alzheimer's disease and Parkinson's disease
Kuo, Y., & De, S. (2023) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2023.104799 · Cited by 3
RetractedUnlocking the Potential of Graphene-Based Nanocomposites in Neurogenesis
Nair, S., Varma, P., & Kandasubramanian, B. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-024-00214-z · Cited by 3
“Additional alternatives for feedstock and pre-deposition optimization configurations are possible in CVD method [21].”
InfluentialSilva-Reis, S. C., Costa, V. M., da Silva, D. C., Pereira, D. M., Correia, X. C., García-Mera, X., Rodríguez-Borges, J. E., & Sampaio‐Dias, I. E. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00584h · Cited by 3
Carbon dots‐based materials and their applications in regenerative medicine
Ma, J., Chen, Q., He, H., Jiang, H., Hu, J., Liu, Y., Yao, L., Mao, H., Li, J., Li, B., et al. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.98 · Cited by 3
Eddin, F. B. K., Fen, Y. W., Liew, J. Y. C., Lim, . N., Fauzi, N. I. M., & Daniyal, . M. E. M. M. (2023) · Optical and Quantum Electronics · doi:10.1007/s11082-023-05476-3 · Cited by 3
“…have revealed that graphene quantum dots (GQDs) films and/or coatings have prospective uses in biomedical (Liu et al. 2017; Qian et al. 2014; Xiao et al. 2016; Li et al. 2017; Zhu et al. 2012a), optical (Zubair et al. 2015; Kim and Kim 2017; Zhang et al. 2018; Tang et al. 2013; Das et al.…”
BackgroundDesign and modulation of two-dimensional Dirac materials in beryllium/boron-based binary monolayers
Chen, J., Sun, B. T., Cai, X., Wang, H., & Chen, Y. (2021) · Computational Materials Science · doi:10.1016/j.commatsci.2021.110727 · Cited by 3
Gusmão, L. A., Metzke, A., Deau, E., Meijer, L., Tedesco, A. C., & Köster, R. W. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c00239 · Cited by 2
Arora, T., & Sharma, S. K. (2023) · International Journal of Alzheimer s Disease · doi:10.1155/2023/1753791 · Cited by 2
“It has been shown that the APP/PS1 mice show de fi cit in spatial memory [24, 25].”
BackgroundMethodInfluentialReview of research of nanocomposites based on graphene quantum dots
Kuznetsov, A. E. (2020) · Physical Sciences Reviews · doi:10.1515/psr-2019-0135 · Cited by 2
Graphene: A Promising Theranostic Agent
Shahriar, S. M. S., Nafiujjaman, M., An, J. M., Revuri, V., Nurunnabi, M., Han, D., & Lee, Y.-K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-4923-3_8 · Cited by 2
Inhibition and Disassembly of Tau Aggregates by Engineered Graphene Quantum DotsPreprint
Zhu, R., Makwana, K. M., Zhang, Y., Rajewski, B. H., Valle, J. R. D., & Wang, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.29.522245 · Cited by 2
A Review On Carbon Dots Use In Neurological Disorder
Singh, N., & Singh, S. (2023) · Journal of Survey in Fisheries Sciences · doi:10.53555/sfs.v8i3.1397 · Cited by 1
Properties of Quantum Dots Based Nanocomposites
Bhui, A. K., Shukla, S., Sen, S., & Dey, A. (2024) · Engineering materials · doi:10.1007/978-3-031-54779-9_5 · Cited by 1
Unravelling amino acid–graphene interactions: insights from polarizable force field simulations
Soni, S., Halder, R., Luniwal, M., & Mallajosyula, S. S. (2025) · Nanoscale · doi:10.1039/d5nr03148f · Cited by 1
Podder, A., Kosara, S., Yadav, S. K., Verma, D., Mishra, D. T. P., Solanki, R., Bhatia, D. D., & Yadav, A. K. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08199 · Cited by 1
Phullay, P., Panwar, R., Bajwa, S., Wadhwa, K., Chauhan, P., Pahwa, R., Kriplani, P., Rajak, H., Awasthi, R., & Dureja, H. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00616-z · Cited by 1
Nanodrug delivery—a noble approach in neurodegenerative disorder and glioblastoma
Mishra, K., & Kakhlon, O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19129-9.00002-9 · Cited by 1
Chebodaeva, V. V., Bakina, O. V., & Sharkeev, Y. P. (2025) · Russian Physics Journal · doi:10.1007/s11182-025-03395-2 · Cited by 1
“Iron stimulates osteoblast proliferation, accelerating the process of bone integration [6].”
Fabrication and analysis of starch-based green materials
Al-Douri, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821163-2.00020-0 · Cited by 1
Carbon Dots -A Turn-On Probe for Neurological Disorder
Mukherjee, P., Chakraborty, M., & Mukhopadhyay, G. (2023) · International Journal of Membrane Science and Technology · doi:10.15379/ijmst.v10i1.2982
“…if you want to prevent NDs. Inhibiting A accumulation while lowering pro-inflammatory cytokines, and tumour necrosis factor-(TNF-) have been shown to improve learning and memory function as well as dendritic spine in GQDs loaded with the neuroprotective peptide glycine-proline-glutamate[116,117].”
BackgroundGraphene‐Based Materials for Brain Targeting
Aderibigbe, B. A., Naki, T., & Owonubi, S. J. (2019) · Wiley eBooks · doi:10.1002/9781119468455.ch120 · Cited by 1
Peptide modified C-dots for bioimaging applications
Anderson, Z. T. (2019) · CLOK (University of Central Lancashire)
Nanoformulations in Human Health Conditions: The Paradigm Shift
Pandey, V., & Kohli, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-41858-8_2
Progress of Nanotechnology-Based Detection and Treatment of Alzheimer’s Disease Biomarkers
Singh, Y. R., Shukla, A., & Pattanayek, S. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-3667-7_3
Therapeutic Potential of Cannabis Plant
Pote, S., Khurana, P., Kaur, G., & Kokane, S. (2023) · International Journal of Plant and Environment · doi:10.18811/ijpen.v9i03.02
“Glycine–proline–glutamate-conjugated graphene quantum dots (GQDGs) were investigated for the treatment of Alzheimer’s disease and were found to have an inhibitory effect on the aggregation of amyloid-βfibrils (Xiao et al. , 2016).”
BackgroundDeeba, F., Chouhan, A. S., Kushwah, V., & Maurya, G. (2024) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2024.036
Wu, T., Liang, X., Liu, X., Li, Y., Wang, Y., Kong, L., & Tang, M. (2020) · Figshare · doi:10.6084/m9.figshare.12644464
Ruan, Y., Xiong, Y., Fang, W., Yu, Q., Mai, Y., Cao, Z., Wang, K., Lei, M., Xu, J., Liu, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20317567
Self-citationZhang, Y., Wang, S., Lu, F., Zhang, M., Kong, H., Cheng, J., Luo, J., Zhao, Y., & Qu, H. (2021) · Figshare · doi:10.6084/m9.figshare.16529918
Wu, T., Wang, X., Cheng, J., Liang, X., Li, Y., Chen, M., Kong, L., & Tang, M. (2022) · Figshare · doi:10.6084/m9.figshare.19418275
Metadata
- Authors
- Xiao, S., Zhou, D., Luan, P., Gu, B., Feng, L., Fan, S., Liao, W., Fang, W., Yang, L., Tao, E., Guo, R., & Liu, J.
- Affiliations
- Sun Yat-sen University (CN)
- Guangdong Provincial Hospital of Chinese Medicine (CN)
- Shenzhen University (CN)
- Jinan University (CN)
- Corresponding author
- Guo, Rui
- Liu, Jun
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 106
- Pages
- 98-110
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2514135347
- Cited by
- 169
- References
- 68
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 25 · 2023: 37 · 2022: 25 · 2021: 22 · 2020: 23 · 2019: 8 · 2018: 11 · 2017: 5
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Shenzhen Fundamental Research and Discipline Layout project
- National Natural Science Foundation of China (81372919)
- Natural Science Foundation of Guangdong Province (51303064, 2014A030313016)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Materials Science › Materials Chemistry › Carbon and Quantum Dots Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- graphene quantum dots, neuroprotective peptides, Alzheimer's disease, amyloid beta aggregation inhibition, APP/PS1 mice, learning and memory, dendritic spines, neuroinflammation, inflammatory cytokines, anti-inflammatory cytokines, amyloid plaques, nanomaterial drug delivery
- MeSH terms
- Alzheimer Disease, Animals, Graphite, Learning, Male, Memory, Mice, Transgenic, Peptides, Treatment Outcome, Neuroprotective Agents, Quantum Dots, Mice, Nanoconjugates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
